Organisation paid for research Program year 2020 Source: CMS Open Payments

Yale Medcn

Neither a doctor nor a teaching hospital

Research payments

$63,226

27 payments

Through program year 2020, Yale Medcn is reported as receiving $63,226 in research payments, across 27 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$46,911	20
2019	Research	$16,315	7

Breakdown

Who paid Research payments · program years 2019–2020

Janssen Research & Development, LLC $63,226 27 payments

Studies the money was for Research payments · program years 2019–2020

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus $44,114 18 payments
A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone (DRd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $12,272 4 payments
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects With Moderately to Severely Active Crohn's Disease $4,435 3 payments
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients (MARINER) $2,405 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.